Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Influenza

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    August 2025
  1. FAN Z, Li J, He L, Li Q, et al
    Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via site-specific microbial transglutaminase labeling.
    Biochem Biophys Res Commun. 2025;775:152162.
    PubMed     Abstract available


    June 2025
  2. PERFILOVA KV, Matyuta IO, Minyaev ME, Boyko KM, et al
    High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2 nucleoprotein variant with improved replicative fitness.
    Biochem Biophys Res Commun. 2025;767:151915.
    PubMed     Abstract available


  3. KOU L, Wan Y, Nemoto YL, Tsujita K, et al
    Role of membrane proximal actin regulators in SARS-CoV-2 spike-induced cell-cell fusion.
    Biochem Biophys Res Commun. 2025;766:151846.
    PubMed     Abstract available


  4. CHU X, Yang Y, Guo H, Ji X, et al
    SARS-CoV-2 NSP2 specifically interacts with cellular protein SmgGDS.
    Biochem Biophys Res Commun. 2025;764:151828.
    PubMed     Abstract available


  5. ZHANG YH, Su AM, Hou XM
    Structural and functional insights into the SARS-CoV-2 SUD domain and its interaction with RNA G-Quadruplexes.
    Biochem Biophys Res Commun. 2025;764:151817.
    PubMed     Abstract available


    April 2025
  6. LIU HL, Lin S, Hung W, Chang DC, et al
    A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system.
    Biochem Biophys Res Commun. 2025;758:151654.
    PubMed     Abstract available


  7. ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al
    Corrigendum to "mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro" [Biochem. Biophys. Res. Commun. 738 (2024) 150945].
    Biochem Biophys Res Commun. 2025 Apr 9:151783. doi: 10.1016/j.bbrc.2025.151783.
    PubMed    


  8. GU L, Wang ZJ, Zhang XR, Liu Y, et al
    Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains.
    Biochem Biophys Res Commun. 2025;756:151594.
    PubMed     Abstract available


  9. KOCHAROVSKAYA MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, et al
    Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
    Biochem Biophys Res Commun. 2025;755:151558.
    PubMed     Abstract available


    March 2025
  10. IMBIAKHA B, Ezzatpour S, Buchholz DW, Poosala S, et al
    Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in mice.
    Biochem Biophys Res Commun. 2025;753:151480.
    PubMed     Abstract available


    February 2025
  11. DU S, Yang L, Chen X, Chen Y, et al
    Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants.
    Biochem Biophys Res Commun. 2025;746:151224.
    PubMed     Abstract available


    January 2025
  12. CULIAT C, Soni D, Malkes W, Wienhold M, et al
    NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune response, and the HIF-1alpha hypoxia pathway to promote healing in viral-induced lung injury.
    Biochem Biophys Res Commun. 2025;744:151198.
    PubMed     Abstract available


    December 2024
  13. HOSOKAWA K, Ohmori H
    Digital reverse transcription PCR using a simple poly(dimethylsiloxane) microwell array chip for detection of SARS-CoV-2.
    Biochem Biophys Res Commun. 2024;741:151070.
    PubMed     Abstract available


  14. ROY A, Paul I, Paul T, Dihidar A, et al
    Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.
    Biochem Biophys Res Commun. 2024;739:150948.
    PubMed     Abstract available


  15. BEGUM F, Chandra S, Mallik MH, Dey J, et al
    A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide.
    Biochem Biophys Res Commun. 2024;739:150579.
    PubMed     Abstract available


  16. ZHAN Y, Li M, Gong R
    Protein mimics of fusion core from SARS-CoV-1 can inhibit SARS-CoV-2 entry.
    Biochem Biophys Res Commun. 2024;736:150857.
    PubMed     Abstract available


    November 2024
  17. SINGH V, Bhutkar M, Choudhary S, Nehul S, et al
    Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.
    Biochem Biophys Res Commun. 2024;734:150746.
    PubMed     Abstract available


  18. ZUBIETE-FRANCO I, Tonks NK
    Famotidine increases cellular phospho-tyrosine levels.
    Biochem Biophys Res Commun. 2024;734:150763.
    PubMed     Abstract available


  19. VISSAPRAGADA M, Addala S, Aggunna M, Sodasani M, et al
    Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19.
    Biochem Biophys Res Commun. 2024;734:150622.
    PubMed     Abstract available


  20. UCHIKUBO-KAMO T, Ishimoto N, Umezawa H, Hirohama M, et al
    Structural insights into Influenza A virus RNA polymerase PB1 binding to nuclear import host factor RanBP5.
    Biochem Biophys Res Commun. 2024;739:150952.
    PubMed     Abstract available


  21. ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al
    mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro.
    Biochem Biophys Res Commun. 2024;738:150945.
    PubMed     Abstract available


    September 2024
  22. KUSHWAHA N, Dwivedi A, Tiwari S, Mishra P, et al
    Comprehensive analytics for virus-cell and cell-cell multinucleation system.
    Biochem Biophys Res Commun. 2024;726:150281.
    PubMed     Abstract available


  23. LI Q, Zhou X, Wang W, Xu Q, et al
    Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease.
    Biochem Biophys Res Commun. 2024;724:150230.
    PubMed     Abstract available


  24. XU J, Zhu Q, Li W, Yin X, et al
    Structural basis for the inhibition of the HCoV-NL63 main protease M(pro) by X77.
    Biochem Biophys Res Commun. 2024;724:150231.
    PubMed     Abstract available


    July 2024
  25. TACHIBANA K, Nakamura Y, Do TL, Kihara T, et al
    Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.
    Biochem Biophys Res Commun. 2024;719:150120.
    PubMed     Abstract available


  26. GAUR NK, Urankar S, Sengupta D, Chepuri VR, et al
    A cell based assay using virus-like particles to screen AM type mimics for SARS-CoV-2 neutralisation.
    Biochem Biophys Res Commun. 2024;718:150082.
    PubMed     Abstract available


  27. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
    Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
    Biochem Biophys Res Commun. 2024;716:149954.
    PubMed     Abstract available


    June 2024
  28. BAI G, Zeng X, Zhang L, Wang Y, et al
    Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
    Biochem Biophys Res Commun. 2024;712-713:149945.
    PubMed     Abstract available


  29. KAWAI A, Hirata H, Tokunoh N, Ono C, et al
    Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier.
    Biochem Biophys Res Commun. 2024;711:149919.
    PubMed     Abstract available


    May 2024
  30. KALASHNYK O, Lykhmus O, Sullivan R, Komisarenko S, et al
    Agonists or positive allosteric modulators of alpha7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
    Biochem Biophys Res Commun. 2024;709:149825.
    PubMed     Abstract available


  31. SU L, Lou Y, Li J, Mao H, et al
    Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR.
    Biochem Biophys Res Commun. 2024;707:149726.
    PubMed     Abstract available


    April 2024
  32. KOMU JG, Jamsransuren D, Matsuda S, Ogawa H, et al
    Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
    Biochem Biophys Res Commun. 2024;715:149994.
    PubMed     Abstract available


    March 2024
  33. HE K, Ye Y, Liu S, Yuan P, et al
    Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus.
    Biochem Biophys Res Commun. 2024;709:149821.
    PubMed     Abstract available


  34. KIM HJ, Han CW, Jeong MS, Jang SB, et al
    Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex.
    Biochem Biophys Res Commun. 2024;706:149728.
    PubMed     Abstract available


    January 2024
  35. SAITO T, Couzinet A, Murakami T, Shimomura M, et al
    Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood.
    Biochem Biophys Res Commun. 2024;694:149398.
    PubMed     Abstract available


  36. NASSAR K, El-Mekawey D, Elmasry AE, Refaey MS, et al
    The significance of caloric restriction mimetics as anti-aging drugs.
    Biochem Biophys Res Commun. 2024;692:149354.
    PubMed     Abstract available


  37. JIANG H, Zou X, Zhou X, Zhang J, et al
    Crystal structure of SARS-CoV-2 main protease (M(pro)) mutants in complex with the non-covalent inhibitor CCF0058981.
    Biochem Biophys Res Commun. 2024;692:149352.
    PubMed     Abstract available


    December 2023
  38. KAWAHARA E, Yamamoto S, Shibata T, Hirai T, et al
    CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4(+) T cells.
    Biochem Biophys Res Commun. 2023;686:149143.
    PubMed     Abstract available


  39. ZHANG L, Zhang X, Deng X, Wang P, et al
    Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.
    Biochem Biophys Res Commun. 2023;686:149118.
    PubMed     Abstract available


    November 2023
  40. CARONIA L, Xi R, Margolskee RF, Jiang P, et al
    Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir.
    Biochem Biophys Res Commun. 2023;682:138-140.
    PubMed     Abstract available


    October 2023
  41. JIANG S, Yang H, Sun Z, Zhang Y, et al
    The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17.
    Biochem Biophys Res Commun. 2023;679:37-46.
    PubMed     Abstract available


  42. FRASER-PITT D, Mercer DK, Francis ML, Toledo-Aparicio D, et al
    Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.
    Biochem Biophys Res Commun. 2023;677:168-181.
    PubMed     Abstract available


  43. YAO Y, Zhang Y, Li Z, Chen Z, et al
    A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Biochem Biophys Res Commun. 2023;675:113-121.
    PubMed     Abstract available


    September 2023
  44. FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al
    High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
    Biochem Biophys Res Commun. 2023;673:114-120.
    PubMed     Abstract available


    August 2023
  45. SUN W, Zhang Z, Chen M, Liu X, et al
    Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
    Biochem Biophys Res Commun. 2023;678:97-101.
    PubMed     Abstract available


  46. YU J, Im H, Lee G
    Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca(2+), elucidated by biochemical and single-molecular studies.
    Biochem Biophys Res Commun. 2023;668:35-41.
    PubMed     Abstract available


    July 2023
  47. BEAUDOIN CA, Petsolari E, Hamaia SW, Hala S, et al
    SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Biochem Biophys Res Commun. 2023;666:61-67.
    PubMed     Abstract available


    June 2023
  48. ISHII H, Jounai K, Tsuji R, Ohshio K, et al
    Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Biochem Biophys Res Commun. 2023;662:26-30.
    PubMed     Abstract available


  49. CHU X, Ding X, Yang Y, Lu Y, et al
    Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
    Biochem Biophys Res Commun. 2023;660:43-49.
    PubMed     Abstract available


    May 2023
  50. ITO K, Goto K, Shirakawa R, Horiuchi H, et al
    Platelet alphaIIbbeta3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains.
    Biochem Biophys Res Commun. 2023;657:80-85.
    PubMed     Abstract available


  51. ZHOU Y, Wang W, Zeng P, Feng J, et al
    Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332.
    Biochem Biophys Res Commun. 2023;657:16-23.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.